131 related articles for article (PubMed ID: 26903363)
21. [A case of malignant lymphoma of the stomach in which preoperative chemotherapy provided a complete response].
Okumoto T; Tomiyama K; Ino H; Kanaya Y; Maruyama S; Otani J; Yokoyama N; Soda M
Gan To Kagaku Ryoho; 2002 Jun; 29(6):943-7. PubMed ID: 12090049
[TBL] [Abstract][Full Text] [Related]
22. Strikingly high false positivity of surveillance FDG-PET/CT scanning among patients with diffuse large cell lymphoma in the rituximab era.
Avivi I; Zilberlicht A; Dann EJ; Leiba R; Faibish T; Rowe JM; Bar-Shalom R
Am J Hematol; 2013 May; 88(5):400-5. PubMed ID: 23423884
[TBL] [Abstract][Full Text] [Related]
23. [Non-Hodgkin lymphoma of the mandible--a case report with differential diagnostic considerations].
Heuberger BM; Weiler D; Bussmann C; Kuttenberger JJ
Schweiz Monatsschr Zahnmed; 2011; 121(5):449-60. PubMed ID: 21656387
[TBL] [Abstract][Full Text] [Related]
24. A case of primary skull lymphoma: review of literature.
Mishra SS; Senapati SB; Dhir MK; Das S; Burma S
Neurol India; 2013; 61(3):334-6. PubMed ID: 23860174
[No Abstract] [Full Text] [Related]
25. Lymphoma of bone with initial presentation as a calvarial mass.
Dai MS; Ho CL; Chen CY; Chen TM; Yu CP; Chao TY
Ann Hematol; 2000 Dec; 79(12):700-2. PubMed ID: 11195009
[TBL] [Abstract][Full Text] [Related]
26. Impressive response to temsirolimus in a patient with chemotherapy refractory diffuse large B-cell non-Hodgkin's lymphoma.
Kiewe P; Thiel E
Ann Hematol; 2011 Jan; 90(1):109-10. PubMed ID: 20387065
[No Abstract] [Full Text] [Related]
27. Hepatitis B virus reactivation in lymphoma patients with prior resolved hepatitis B undergoing anticancer therapy with or without rituximab.
Yeo W; Chan TC; Leung NW; Lam WY; Mo FK; Chu MT; Chan HL; Hui EP; Lei KI; Mok TS; Chan PK
J Clin Oncol; 2009 Feb; 27(4):605-11. PubMed ID: 19075267
[TBL] [Abstract][Full Text] [Related]
28. Subcutaneous Dissemination from an Orbital Diffuse Large B Cell Lymphoma.
Bains S; Vidhya N; Kim U; Shanti R; Devanand J
Orbit; 2015; 34(6):338-9. PubMed ID: 26452055
[TBL] [Abstract][Full Text] [Related]
29. [Primary diffuse large B-cell lymphoma in uterine corpus: report of a case].
Dong W; Cao L; Wang DS
Zhonghua Bing Li Xue Za Zhi; 2011 Apr; 40(4):270-2. PubMed ID: 21616007
[No Abstract] [Full Text] [Related]
30. Diffuse large B-cell lymphoma with germinal center B-cell phenotype mimicking primary effusion lymphoma.
Lim Y; Kim TY; Choi IS; Kim BS; Lee TS; Kim JE; Chang MS; Kim KH
J Clin Oncol; 2011 Apr; 29(10):e271-3. PubMed ID: 21220599
[No Abstract] [Full Text] [Related]
31. [Treatment approaches for diffuse large B-cell lymphoma].
Miyazaki K; Yamaguchi M
Nihon Rinsho; 2014 Mar; 72(3):483-7. PubMed ID: 24724408
[TBL] [Abstract][Full Text] [Related]
32. A study on nm23-H1 expression in diffuse large B-cell lymphoma that was treated with CyclOBEAP plus rituximab therapy.
Niitsu N; Tamaru J; Yoshino T; Nakamura N; Nakamura S; Ohshima K; Nakamine H; Okamoto M
Ann Hematol; 2011 Feb; 90(2):185-92. PubMed ID: 20809421
[TBL] [Abstract][Full Text] [Related]
33. Primary bilateral adrenal lymphoma revealed by hemophagocytic syndrome.
Alaoua A; Gilbert G; Ghannouchi N; Houchlef M; Letaief A; Bahri F
Ann Endocrinol (Paris); 2011 Jun; 72(3):247-50. PubMed ID: 21640976
[TBL] [Abstract][Full Text] [Related]
34. Complete response to chemotherapy in primary hepatic lymphoma.
Zafar MS; Aggarwal S; Bhalla S
J Cancer Res Ther; 2012; 8(1):114-6. PubMed ID: 22531527
[TBL] [Abstract][Full Text] [Related]
35. Non-multiple lymphomatous polyposis form of mantle cell lymphoma in the gastrointestinal tract.
Tamura S; Ohkawauchi K; Yokoyama Y; Higashidani Y; Daibata M; Hiroi M; Yamamori S; Onishi S
J Gastroenterol; 2004 Oct; 39(10):995-1000. PubMed ID: 15549454
[TBL] [Abstract][Full Text] [Related]
36. Composite diffuse large B-cell lymphoma and CD20-positive peripheral T-cell lymphoma.
Yamazaki S; Fujioka Y; Nakamura F; Ota S; Shinozaki A; Yamamoto G; Kamikubo Y; Nannya Y; Ichikawa M; Fukayama M; Kurokawa M
Pathol Int; 2011 Nov; 61(11):662-6. PubMed ID: 22029677
[TBL] [Abstract][Full Text] [Related]
37. Characteristics of Bone Destruction in Cranial Vault Lymphoma Compared with Other Skull Tumors.
Umemura T; Nakano Y; Soejima Y; Saito T; Kitagawa T; Miyaoka R; Suzuki K; Yamamoto J
J UOEH; 2019; 41(3):335-342. PubMed ID: 31548488
[TBL] [Abstract][Full Text] [Related]
38. Interim PET/CT-based prognostic model for the treatment of diffuse large B cell lymphoma in the post-rituximab era.
Yang DH; Ahn JS; Byun BH; Min JJ; Kweon SS; Chae YS; Sohn SK; Lee SW; Kim HW; Jung SH; Kim YK; Kim HJ; Bom HS; Lee JJ
Ann Hematol; 2013 Apr; 92(4):471-9. PubMed ID: 23238895
[TBL] [Abstract][Full Text] [Related]
39. Limited role of interim PET/CT in patients with diffuse large B-cell lymphoma treated with R-CHOP.
Yoo C; Lee DH; Kim JE; Jo J; Yoon DH; Sohn BS; Kim SW; Lee JS; Suh C
Ann Hematol; 2011 Jul; 90(7):797-802. PubMed ID: 21181163
[TBL] [Abstract][Full Text] [Related]
40. Reversible posterior leukoencephalopathy syndrome following R-CHOP therapy for diffuse large B-cell lymphoma.
Hosoi M; Yamamoto G; Imai Y; Kurokawa M
Ann Hematol; 2010 Feb; 89(2):207-8. PubMed ID: 19582454
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]